A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Metronidazole Administered Alone and in Combination With MMX Mesalazine/Mesalamine in Healthy Adult Subjects.

Trial Profile

A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Metronidazole Administered Alone and in Combination With MMX Mesalazine/Mesalamine in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Mesalazine (Primary) ; Metronidazole
  • Indications Bacterial infections; Crohn's disease; Ulcerative colitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Oct 2012 Results presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology.
    • 17 Oct 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
    • 17 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top